Skip to main content Help with accessibility Skip to main navigation

ALIROCUMAB solution for injection (Praluent®▼) for reduction of cardiovascular risk in adults with established atherosclerotic cardiovascular disease

CCG Approval Status:

Date Added: 26 - Apr - 2019
Body System:
Grey

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of ALIROCUMAB solution for injection (Praluent®▼) for reduction of cardiovascular risk in adults with established atherosclerotic cardiovascular disease.